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Abstract
Coxiella burnetii is the causative agent of Q fever. Q fever is a worldwide zoonosis that is
responsible for various clinical manifestations. However, in Greece hepatitis due to Coxiella is
rarely encountered. A case of Q fever associated with hepatitis is reported here. Diagnosis was
made by specific serological investigation (enzyme-linked immunosorbent and indirect
immunofluorescene assays) for Coxiella burnetii.
Introduction
Q fever is caused by the obligate intracellular bacterium
Coxiella burnetii. The primary reservoirs of infection are
farm animals such as cattle, goats and sheep. Pets, includ-
ing cats, rabbits and dogs, have also been identified as
potential sources of human infection. The infected mam-
mals shed the microorganism in urine, feces, milk and
especially birth products [1]. The disease can be transmit-
ted mainly through contact with infected animals, inhala-
tion of contaminated aerosols and ingestion of
unpasteurized products. Incidents following blood trans-
fusion, skin trauma and sexual contact have been rarely
reported. The clinical presentation of Coxiella burnetii is
very pleomorfic and non-specific. The infection has two
forms, acute and chronic, whereas half of the patients
remain asymptomatic.
Among those who are symptomatic the acute form is typ-
ically manifested as pneumonia, flu-like syndrome, hepa-
titis and rarely as Guillain-Barre or lymphadenopathy.
Endocarditis is the main clinical form of chronic Q fever
and mostly affects patients with underlying valvulopathy.
Reports from several places in Europe, such as Great Brit-
ain [2], Spain [3], France [4] and Crete, Greece [5] indicate
that epidemiological and clinical features of Q fever vary
from area to area. Q fever in northern Greece has been
rarely reported and may remain underdiagnosed [6].
Case presentation
In December 2005, a patient aged 22 years was admitted
to the emergency department of AHEPA University Hospi-
tal of Thessaloniki due to persistent (5 days) high grade of
fever (38.5°C) and pharyngalgia. On physical examina-
tion no specific clinical signs were present. The initial lab-
oratory tests were normal and chest X ray did not reveal
any lung disease. Empiric antibacterial therapy (clarithro-
mycin 500 mg × 2 for 5 days) and non-steroidal anti-
inflammatory agent (nimesulid 100 mg × 2 for 3 days) for
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persisted and the patient also developed fatigue, chills,
anorexia, headaches, myalgia and skin rash (pink macular
lesions of the trunk). When he revisited the emergency
department, he was hospitalized for further diagnostic
evaluation. The patient had no history of contact with ani-
mals, exposure to hepatotoxic agents, like alcohol, drugs,
recent history of blood transfusion, or surgical/dental
operation.
On clinical examination, jaundice, mild hepatomegaly
and skin rash were detected. Chest X ray was found nor-
mal and abdominal ultrasound revealed mild hepatome-
galy without biliary tract obstruction. Laboratory
examinations revealed leukopenia (WBC 2.9 × 109/L),
thrombocytopenia (PLT 130 × 109/L), moderate hyperbi-
lirubinemia -mainly direct bilirubin- (T-Bil 3 mg/dL), ele-
vated serum C-reactive protein (2.95 mg/dl) and
increased hepatic enzyme levels [ALT: 250 U/L (nor-
mal:0–40 U/L), AST: 380 U/L (normal:0–39 U/L), LDH:
900 (normal:240–480 U/L)], whereas cholostatic
enzymes (ALP, γ-GT) were found nearly normal.
The patient did not exhibit autoantibodies, including
smooth muscle, anticardiolipin, antiphospholipid and
antinuclear antibodies. Serologic tests for HIV-1, EBV,
CMV, Mycoplasma, Rickettsia, Chlamydia, Bartonella,
Parvovirus B19, hepatitis A, B, and C viruses were nega-
tive. Q fever was added to the list of differential diagnosis,
although exposure to cattle, sheep, goats or consumption
of unpasteurized products was not reported. Additionally,
a heart ultrasound was performed and pericarditis or
myocarditis were excluded.
The diagnosis of acute Q fever was confirmed by serologic
methods. Serum samples were tested initially by enzyme-
linked immunosorbent assay (ELISA) and its positive
result [IgG I (1,1x cutoff), IgG II 41 IU/ml)] was con-
firmed by indirect immunofluorescene assay (IFA). IgG
antibodies were reactive with phase I and II antigens of C.
burnetii at titers 1:64 and 1:256 respectively. The patient
was administered moxifloxacin 400 mg once a day per os
for 14 days. The symptoms resolved within 2 weeks,
whereas the levels of hepatic transaminases were mildly
elevated [ALT: 55 U/L, AST:63 U/L, T-Bilirubin:1,6 mg/dl].
A convalescent-phase serum sample was obtained 3 weeks
later, confirming the initial diagnosis. It was also tested by
ELISA [IgG I (1,9x cutoff), IgG II 149 IU/ml)] and IFA [IgG
I 1:256, IgG II 1:1024]. During a follow-up visit 3 months
after hospitalization, the patient was clinically asympto-
matic and had normal hepatic enzymes.
Discussion
Although described years ago, Q fever is still a poorly
understood disease. The clinical manifestations of Q fever
may be so variable that the disease is often diagnosed only
if it has been systematically considered. Many times, it is
diagnosed as a form of atypical pneumonia with or with-
out liver participation, whereas in our case there was no
pulmonary disease. Q fever hepatitis has been rarely
reported in Greece [7]. Results of this study suggest, how-
ever, that acute Q fever should be added to the list of dif-
ferential diagnosis of patients with fever and elevated
serum transaminase levels [8,9], irrespective of the pres-
ence of abdominal pain, jaundice and exposure to poten-
tially infected animals.
Conclusion
Q fever is certainly not the first diagnosis to consider in a
patient presenting with fever, rash and constitutional
symptoms and as far as we are concerned, it is not rou-
tinely tested in most laboratories. In cases with clinical
and epidemiological findings compatible with Q fever,
coxiella testing should be offered.
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